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Deriving ligand orientation on weak protein-ligand complexes by 
DEEP-STD NMR in the absence of protein chemical shift 
assignment 
Ridvan Nepravishta,ϯ[a] Samuel Walpole, ϯ[a] Louise Tailford,[b] Nathalie Juge[b] and Jesus Angulo*[a] 
DEEP-STD NMR is a recently developed powerful approach for 
structure and pharmacophore elucidation of weak protein-
ligand interactions, reporting key information on the orientation 
of the ligand and the architecture of the binding pocket.[1]  The 
method relies on selective saturation of protein residues in the 
binding site and the generation of a differential epitope map by 
observing the ligand, which depicts the nature of the protein 
residues contacting the ligand in the bound state. Selective 
saturation requires knowledge of the chemical shift assignment 
of the protein residues, which can be obtained either 
experimentally by NMR or predicted from 3D structures. Here 
we propose a simple experimental procedure to expand the 
DEEP-STD NMR methodology to protein-ligand cases where the 
spectral assignment of the protein is not available. This is 
achieved by experimentally identifying the chemical shifts of 
the residues present in binding hot-spots on the surface of the 
receptor protein using 2D NMR experiments combined with 
addition of a paramagnetic probe.  
The 3D structure of a small bioactive molecule in complex with 
its receptor gives important atomic information essential for 
understanding biological effects triggered by biomolecular 
recognition processes, as well as for the discovery and design of 
new drugs. There are several techniques used to achieve this 
aim, with X-ray crystallography, NMR spectroscopy and more 
recently cryo-EM being the most relevant approaches.  
 Recently, we have developed the DiffErential EPitope 
mapping saturation transfer difference (DEEP-STD) NMR 
methodology for weak protein-ligand interactions,[1] as an 
extension of the general STD NMR method.[2] The DEEP-STD 
NMR technique allows the orientation of the ligand to be derived, 
through differential selective saturation of different sets of key 
protein residues in the binding site.  Namely, two STD NMR 
experiments are carried out, each one saturating different sets of 
protein residues, and the difference between the resulting 
spectra is quantified and mapped onto the ligand structure 
(differential epitope map). In order to accurately perform the 
DEEP-STD NMR experiment, it is of paramount importance to 
know beforehand the chemical shifts of the residues present in 
the binding site, in order to identify which set of residues to 
target, i.e. choosing the irradiation frequencies to ensure that the 
selective saturation is applied on residues that are present in the 
binding site. Experimental chemical shifts can be obtained by 
NMR, or derived from a 3D structure obtained by X-ray 
diffraction or by homology modelling.[3] The experimental DEEP-
STD factors can be further combined with molecular docking 
and STD intensity predictions by CORCEMA-ST[4] in order to 
select the docking model that best fits the experimental data. 
 In the absence of chemical shift assignment of the receptor 
protein, we hereby propose a general approach to 
experimentally identify the chemical shifts of those binding 
pocket resonances, which relies on the identification of ligand 
binding hot-spots on the surface of the protein (a ligand-binding 
hot-spot is a site on the surface of the protein that has a high 
probability for interaction with a ligand[5]) using 2D NMR 
spectroscopy. This approach is compatible with the STD NMR 
technique, inexpensive, and relatively fast which should allow 
broad applicability.  
For large proteins, the slow molecular tumbling in solution 
is characterized by an overall correlation time expected to be in 
the range of 10-8 seconds. However, the internal correlation time 
of the surface residues of globular proteins may be significantly 
shorter. As a result, residues in the core of the protein follow a 
slow-motion regime due to their low flexibility, causing the 
signals to become broadened beyond detection. Conversely, the 
greater flexibility of surface residues causes them to follow a fast 
motion regime leading to cross-peaks in 2D NMR experiments 
that will be narrower and hence detectable. Therefore, these 
spectra are more likely to display signals from residues exposed 
on the surface or in very flexible regions of the protein.[6]   
Using 2D 1H-1H TOCSY experiments, hot-spot mapping 
can be readily achieved by adding paramagnetic probes to the 
protein sample such as 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-
oxyl (TEMPOL).[7] A decrease in intensity of specific protein 
TOCSY cross peaks, compared with the spectra recorded 
without the paramagnetic probe, allows those residues 
interacting with the probe to be easily identified, since they are 
affected by the paramagnetic relaxation enhancement (PRE) 
effect.[8,9] Previous PRE studies with TEMPOL have 
demonstrated the greater accessibility of this paramagnetic 
probe to protein specific binding sites rather than surface 
regions.[7,10,11] As a result of these experiments, the identified 
hot-spot resonances will then be considered as input 
frequencies for the DEEP-STD NMR experiments. 
 The identification of binding hot-spots on the surface of 
proteins has previously been achieved by NMR spectroscopy 
using paramagnetic probes along with classical molecular 
dynamics as well as Mixed Molecular Dynamics using 5-50% 
probe-water mixtures.[7,12,13] For the development of our protocol, 
we combined this approach with DEEP-STD NMR using the 
structurally-characterized catalytic domain (belonging to 
glycoside hydrolase family 33, GH33) of the intramolecular 
trans-sialidase (IT-sialidase) from the human gut symbiont 
Ruminococcus gnavus, RgNanH-GH33 in complex with 2,7-
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anhydro-Neu5Ac (PDB code 4X4A)  as a benchmark.[14]  The 
RgNanH-GH33 enzyme is a 489 residue domain which can be 
considered out of the typical range for swift assignment and 
structure determination by NMR spectroscopy and was 
previously used for the development of the DEEP-STD NMR 
approach.[1] 
We first performed 2D homonuclear 1H-1H TOCSY 
experiments on RgNanH-GH33. The protein was exchanged in 
10 mM Tris-d11 D2O buffer pH 7.8 and 100 mM NaCl and used at 
a concentration of 1.2 mM. First, a 2D 1H-1H TOCSY reference 
spectrum of the protein was acquired, which was followed by 
two spectra in the presence of 2 mM and 12 mM of the 
paramagnetic probe TEMPOL. The spectra (Figure 1 a, b, c) 
obtained in the absence and in the presence of increasing 
concentrations of TEMPOL showed that the probe selectively 
interacts with some residues of the protein, as only some 
resonances in the spectra were significantly affected, as seen by 
a decreased intensity. The chemical shifts most affected by the 
presence of TEMPOL were 0.6, 0.74, 1.06, 1.15, 1.26, 6.6, 6.74, 
7.04, 7.57, 8.56 ppm (Supporting Information Figure S1). These 
resonances, although lacking a specific assignment, are typical 
of aliphatic and aromatic amino acids, while we can exclude the 
presence of the NH resonances in the spectra due to the fact 
that the protein was solvated in a D2O buffer. The identified 
resonances from the TEMPOL-attenuated TOCSY spectra of 
RgNanH-GH33 were indeed in very good agreement with the 
predicted chemical shifts of key aliphatic and aromatic residues 
in the binding pocket of the enzyme (Ile-258, Ile-338, Val-502, 
Thr-557, Tyr-525, Tyr-677, and Trp-698).[1]  
To further validate our approach and exclude false 
positives (i.e., binding hot-spots outside the binding site), we 
carried out molecular dynamics (MD) simulations, an approach 
successfully used in the past to identify ligand binding pockets 
for the development of small molecule inhibitors.[15] Here, MD 
simulations were used to confirm the accessibility of TEMPOL to 
the specific binding pocket of RgNanH-GH33. To efficiently 
explore the configurational space of the RgNanH-GH33-
TEMPOL system, three different MD approaches were 
considered: (i) long MD (1.0  µs) with low concentration of 
TEMPOL (10 mM) starting from a random configuration of the 
system, (ii) 16 independent replicas of short MD (0.8 µs total 10 
mM of TEMPOL), and (iii) 16 independent short replica MD 
simulations with a high concentration (50% w/w) of TEMPOL in 
water known as the MixMD approach.[12] 
In each case, we first analyzed the backbone RMSD of 
RgNanH-GH33 for each trajectory and showed that the 
presence of TEMPOL did not affect the structure of the protein, 
even with MixMD, in which the solvent contained 50% w/w 
TEMPOL, as the average backbone RMSD was only 
approximately 1 Å (see Supporting Information). In the case of 
the long MD and the 16 short replicas, in which there were 
relatively few molecules of TEMPOL in the simulation, the 
interaction between TEMPOL and RgNanH-GH33 was analysed 
by computing the contacts between TEMPOL and each residue 
in RgNanH-GH33 over the course of each trajectory, in order to 
construct a fractional occupancy map for each residue. In the 
case of MixMD, in which there were 381 molecules of TEMPOL 
in the bounding box, the occupancy was measured by using a 
0.5 Å grid to create bins for each TEMPOL molecule in each 
frame of the trajectory. The resulting 3D histograms were then 
visualized by means of the isomesh feature in PyMOL,[16] using  
 
Figure 1. Expansion of the aromatic spectral region of the TOCSY spectra of 
RgNanH-GH33 1.2 mM in the absence a), in the presence of 2 mM b), and 12 
mM c), of the paramagnetic probe TEMPOL. Red circles highlight some 
resonances affected by the presence of TEMPOL (see also Supporting 
Information Figure S1). 
a structure averaged over the whole trajectory for RgNanH-
GH33 (Figure 2).  
Firstly, the long MD simulation containing a low 
concentration of TEMPOL did map several binding hot-spots 
including the area of the binding site, but the outcome was 
dependent on the starting coordinates of the system. To 
overcome this issue, the same experiment was repeated with 16 
different independent short replicas of 50 ns each, following a 
previous protocol.[7] In this case, although mapping of the binding 
hot-spots was clear, the extension of sampling of the surface 
was not complete (Supporting Information Figure S5). Using the 
MixMD approach, high concentrations of the probe enabled 
most of the protein surface to be mapped in a short time. In 
order to avoid biasing the system by the starting coordinates, 12 
independent trajectories were run starting from different initial 
random configurations of the system. Figure 2 displays the 
average structure of the protein together with the occupancy grid, 
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showing that the area of the known binding site of the 2,7-
anhydro-Neu5Ac ligand is the major site for the interaction with 
the paramagnetic probe. 
 
Figure 2. Distribution of TEMPOL (red mesh) around RgNanH-GH33 (grey 
cartoon) as determined by MixMD. The distribution reveals a single large hot-
spot at the known 2,7-anhydro-Neu5Ac binding site, revealing that TEMPOL 
can act as a probe to selectively target residues of the binding site. 
This result clearly excludes the presence of false positives 
and, more importantly, confirms that TEMPOL is selective for the 
binding site. Together with the TEMPOL/RgNanH-GH33 
interaction TOCSY experiment, these MD data build a solid 
argument for the use of TEMPOL-based TOCSY experiments to 
identify specific chemical shifts from residues in the binding 
pocket to perform the DEEP-STD NMR experiments.  
We then carried out the DEEP-STD NMR study using the 
frequencies identified by the TEMPOL approach. RgNanH-GH33 
(50 uM) in the presence of 2,7-anhydro-Neu5Ac (1 mM) in 10 
mM Tris-d11 D2O buffer pH 7.8 and 100 mM NaCl at 298 K was 
saturated with a train of Gaussian pulses of 50 ms each for 0.75 
seconds, centered on the chemical shifts of the binding hot-
spots 0.6, 0.74, 1.06, 1.15, 1.26, 6.6, 6.74, 7.04, 7.57, 8.56 ppm.  
Since the absence of chemical shift assignment of the 
protein prevents the irradiation frequencies to specific protons in 
the binding pocket from being known, we propose here a novel 
approach: instead of using a single pair of frequencies for 
determining the differential epitope map of the ligand (DEEP-
STD map)[1], an averaging approach should be followed. First, 
the DEEP-STD factors are calculated for each experiment 
resulting from all the possible pairs of aliphatic and aromatic 
frequencies experimentally identified before (Supporting 
Information Figure S3). In our case, this resulted in a total of 25 
differential epitope maps. Finally, all the obtained DEEP-STD 
factors are averaged to obtain a unique DEEP-STD map. This 
approach produces a more accurate depiction of the orientation 
and the nature of the amino acids surrounding the ligand in the 
binding pocket, particularly when no chemical shifts from the 
protein are available. 
Figure 3a shows the resulting experimental average 
DEEP-STD map of 2,7-anhydro-Neu5Ac binding to RgNanH-
GH33. 
 
Figure 3. a) Experimental average DEEP-STD factors of the binding of 2,7-
anhydro-Neu5Ac to RgNanH-GH33, obtained from 25 differential epitope 
maps through selective saturation at pairs of frequencies from the two sets 
experimentally determined by the TOCSY+TEMPOL experimental approach; 
set 1 (0.6, 0.74, 1.06, 1.15, 1.26 ppm) and set 2 (6.6, 6.74, 7.04, 7.57, 8.56 
ppm) (see Supporting Information Figure S3). b) Theoretical average DEEP-
STD factors calculated with CORCEMA-ST using ranges of saturation 
frequencies comprehending the experimental values in the calculation.  
The map highlights that CH3, H3a, H3eq, H5 are oriented 
toward aliphatic residues protons, whereas H6, H7, H4 present 
little to no preferred orientation, and finally H9, H9’ and H8 
protons are oriented toward aromatic residues. This result is in 
excellent agreement with the crystal structure of the complex 
between 2,7-anhydro-sialic acid and RgNanH-GH33.[1] To 
confirm that our average DEEP-STD map is a reliable 
representation of the architecture of the binding pocket, we 
further carried out a comparison to theoretical predictions of the 
average DEEP-STD map using the CORCEMA-ST approach 
(see Supporting information).[4] The calculated average DEEP-
STD factors shown in Figure 3b using CORCEMA-ST are in 
excellent agreement with the experimentally obtained ones. This 
result further validates our approach, demonstrating that the 
TEMPOL-based TOCSY approach is a reliable and powerful 
approach for the identification of the suitable set of saturating 
frequencies to carry out DEEP-STD NMR studies in the absence 
of protein chemical shift assignment.  
About the general applicability of this approach, although 
here we have applied it to an enzyme with a polar binding 
pocket favoring H-bond interactions with TEMPOL, it has been 
previously shown that the interaction between proteins and 
TEMPOL can involve weak van der Waals forces, hydrogen 
bonding and hydrophobic interactions. Several authors have 
described interactions of TEMPOL with proteins such as 
Ubiquitin, Lysozyme, Tendamistat, Sso7d, Cyclophyllin, BTPI [17-
22] presenting different hydrophobicity/hydrofilicity profiles in their 
binding sites, which makes us confident on the general 
applicability of the new protocol for different types of protein 
targets.  Yet, some expected limitations are that TEMPOL 
should bind the protein with low affinity, to allow an easy 
interpretation of the spectra in the absence and in the presence 
of the paramagnetic agent, and it should not induce changes in 
the conformation of the protein upon binding, which would lead 
to misinterpretation of resonances to consider for DEEP-STD 
10.1002/cbic.201800568
Ac
ce
pt
ed
 M
an
us
cr
ip
t
ChemBioChem
This article is protected by copyright. All rights reserved.
COMMUNICATION          
For internal use, please do not delete. Submitted_Manuscript 
 
 
NMR or to conformational instability of the protein. It is also 
worth noting the competition of TEMPOL with water tightly 
bound to the protein, that in unfavorable cases might prevent the 
probe to approach the protein surface.[18]  
In summary, we have developed a simple experimental 
procedure to expand the field of application of the DEEP-STD 
NMR methodology for deriving ligand orientation to protein-
ligand cases where the spectral assignment of the protein is not 
available i.e. when (i) a full NMR assignment is not possible, (ii) 
the predicted chemical shifts from the structure are not in line 
with the experimental data (e.g. due to the dynamics of the 
protein, not accounted for in calculations using a static X-ray 
structure), or (iii) chemical shift assignments are lacking. 
Combining 2D TOCSY experiments in the absence/presence of 
a paramagnetic probe, with the determination of an average 
DEEP-STD map via saturation at all the experimentally 
determined frequencies, has been demonstrated to be a 
powerful approach to allow the type of protein residues most 
likely to interact with the ligand to be determined. The obtained 
information on the orientation of the ligand in the binding pocket 
of the protein opens several interesting applications of the 
DEEP-STD NMR methodology, for example in the hit-to-lead 
stage of drug discovery as in 3D-QSAR studies. Further, if 
combined with the KD of the complex, the experimentally 
obtained averaged DEEP STD factors can be used as 
descriptors to evaluate success or failure of hit modifications 
during the hit-to-lead stage.  
Acknowledgments  
This work was supported by the Biotechnology and biological Sciences 
Research Council (BBSRC) through a New Investigator grant awarded 
to J.A. (BB/P010660/1). N.J. and L.E.T. acknowledge funding by the 
BBSRC Institute Strategic Programmes for Gut Health and Food Safety 
(BB/J004529/1) and Gut Microbes and Health (BB/R012490/1). We 
also acknowledge access to UEA Faculty of Science Research Facilities. 
Data supporting this article are available upon request to the 
corresponding author. 
 
 
Keywords:    
[1] S. Monaco, L. E. Tailford, N. Juge, J. Angulo, Angew. Chem. Int. Ed.             
2017,129 (48), 15491–15495. 
[2] a) M. Mayer, B. Meyer, Angew. Chem. Int. Ed. 1999, 38, 1784-1788; b) 
M. Mayer, B. Meyer, J. Am. Chem. Soc. 2001, 123, 6108-6117; c) A. 
Viegas, J. Manso, Nobrega F.L., Cabrita E.J. J.Chem.Ed. 2011, 88 (7), 
990-994. d) J. Angulo, P. M. Nieto, Eur. Biophys. J  2011, 40, 1357-
1369. e) A. Bhunia, S. Bhattacharjya, S. Chatterjee, Drug Discovery 
Today 2012, 17, 505-513. 
[3] B. Han, Y. Liu, S. Ginzinger, D. Wishart. SHIFTX2: significantly 
improved protein chemical shift prediction. J. Biomol. NMR. 2011, 50 
(1), 43-57 
[4] V. Jayalakshmi, N. R. J. Krishna, J. Magn. Reson. 2004, 168, 36−45. 
[5]  B. S. Zerbe, D.R. Hall, S. Vajda, A. Whitty,    D.  Kozakov, J. Chem. Inf. 
Model. 2012, 27;52(8), 2236-44.  
[6] M. A. Keniry, J.A. Carver. Annual Reports On NMR Spectroscopy, Vol. 
48 (Ed. G. A. Webb), Academic Press, London, 2002, pp. 32-63. 
[7] N. Niccolai, E. Morandi, S. Gardini, V. Costabile, R. Spadaccini, O. 
Crescenzi, D. Picone, O. Spiga, A. Bernini. Biochim. Biophys. Acta. 
2017, 1865(2), 201-207. 
[8] I. Solomon Phys. Rev. 1955, 99, 559-566  
[9] G. M. Clore, J. Iwahara. Chem. Rev. 2009, 109(9), 4108-4139.  
[10] S. W. Fesik, G. Gemmecker, E. T. Olejniczak, A. M. Petros. J. Am. 
Chem. Soc. 1991, 113, 7080-7082 
[11]    A. M. Petros, L. Mueller, K. D. Kopple. Biochemistry 1990, 29, 10041-
10048  
[12] P. M. Ung, P. Ghanakota, S. E. Graham, K. W. Lexa, H. A. Carlson.  
Biopolymers. 2016, 105(1):21-34. 
[13] K. W. Lexa, H. A. Carlson. J. Chem. Inf Model. 2013, 25;53(2), 391-402 
[14] L. E. Tailford, C. D. Owen, J. Walshaw, E. H. Crost, J. Hardy-Goddard,      
G. Le Gall, W. M. de Vos, G. L. Taylor, N. Juge, Nat. Commun. 2015, 
6:7624, 1-12.  
[15] J. Seco, F.J. Luque, X. Barril. J Med Chem. 2009,52(8):2363-71. 
[16] The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
[17] N. Niccolai, O. Spiga, A. Bernini, M. Scarselli, A. Ciutti, I. Fiaschi, S. 
Chiellini, H. Molinari, P. A. Temussi. J. Mol. Biol. 2003, 332(2), 437-47. 
[18] M. Scarselli, A. Bernini, C. Segoni, H. Molinari, G. Esposito, A. M. Lesk, 
F. Laschi, Temussi P, Niccolai N. J. Biomol. NMR. 1999, 15 (2), 125-33. 
[19] N. Niccolai, R. Spadaccini, M. Scarselli, A. Bernini, O. Crescenzi, O. 
Spiga, A. Ciutti, D. Di Maro, L. Bracci, C. Dalvit, P. A. Temussi. Protein 
Sci. 2001, 10(8), 1498-507. 
[20] A. Bernini, V. Venditti, O. Spiga, A. Ciutti, F. Prischi, R. Consonni, L. 
Zetta, I. Arosio, P. Fusi, A. Guagliardi, N. Niccolai. Biophys. Chem. 
2008, 137(2-3), 71-5. 
[21] G. Pintacuda, G. Otting. J. Am. Chem. Soc. 2002, 23;124(3), 372-3. 
[22] S. W. Fesik, G. Gemmecker, E. T. Olejniczak, and A. M. Petros. J. Am. 
Chem. Soc., 1991, 13, 7080-708. 
 
 
 
  
10.1002/cbic.201800568
Ac
ce
pt
ed
 M
an
us
cr
ip
t
ChemBioChem
This article is protected by copyright. All rights reserved.
COMMUNICATION          
For internal use, please do not delete. Submitted_Manuscript 
 
 
 
 
Entry for the Table of Contents (Please choose one layout) 
 
Layout 2: 
COMMUNICATION 
 
Text for Table of Contents 
 Ridvan Nepravishta, Samuel 
Walpole, Louise Tailford, Nathalie 
Juge and Jesus Angulo* 
Page No. – Page No. 
Deriving ligand orientation on 
weak protein-ligand complexes 
by DEEP-STD NMR in the 
absence of protein chemical 
shift assignment 
 
 
 
 
 
 
 
 
Paramagnetic probes assist DEEP-STD NMR experiments to be able to provide 
information on ligand orientation in a protein-ligand complex even if the protein 
chemical shifts are unknown. 
 
10.1002/cbic.201800568
Ac
ce
pt
ed
 M
an
us
cr
ip
t
ChemBioChem
This article is protected by copyright. All rights reserved.
